nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Can single-patient investigational new drug studies hurry slow trains to the fast track?
|
Chenoweth, Dale |
|
2006 |
11 |
5-6 |
p. 185-186 2 p. |
artikel |
2 |
Defining and maintaining a high quality screening collection: the GSK experience
|
Lane, Stephen J. |
|
2006 |
11 |
5-6 |
p. 267-272 6 p. |
artikel |
3 |
Dual-action peptides: a new strategy in the treatment of diabetes-associated neuropathy
|
Tam, Joseph |
|
2006 |
11 |
5-6 |
p. 254-260 7 p. |
artikel |
4 |
Host–pathogen systems biology
|
Forst, Christian V. |
|
2006 |
11 |
5-6 |
p. 220-227 8 p. |
artikel |
5 |
Immunomics: discovering new targets for vaccines and therapeutics
|
De Groot, Anne S. |
|
2006 |
11 |
5-6 |
p. 203-209 7 p. |
artikel |
6 |
Joseph Miletich talks about big Pharma, biotech and the future of Amgen
|
Carney, Steve |
|
2006 |
11 |
5-6 |
p. 188-190 3 p. |
artikel |
7 |
Keynote review: Allosterism in membrane receptors
|
Gao, Zhan-Guo |
|
2006 |
11 |
5-6 |
p. 191-202 12 p. |
artikel |
8 |
Monitor
|
Edwards, Paul |
|
2006 |
11 |
5-6 |
p. 274-275 2 p. |
artikel |
9 |
Monitor
|
Edwards, Paul |
|
2006 |
11 |
5-6 |
p. 273-274 2 p. |
artikel |
10 |
New directions in kinetic high information content assays
|
Simpson, Peter B. |
|
2006 |
11 |
5-6 |
p. 237-244 8 p. |
artikel |
11 |
Structure-based development of target-specific compound libraries
|
Orry, Andrew J.W. |
|
2006 |
11 |
5-6 |
p. 261-266 6 p. |
artikel |
12 |
Targeting N-type and T-type calcium channels for the treatment of pain
|
McGivern, Joseph G. |
|
2006 |
11 |
5-6 |
p. 245-253 9 p. |
artikel |
13 |
The promise of a virtual lab in drug discovery
|
Rauwerda, Han |
|
2006 |
11 |
5-6 |
p. 228-236 9 p. |
artikel |
14 |
What makes a good anti-inflammatory drug target?
|
Simmons, David L. |
|
2006 |
11 |
5-6 |
p. 210-219 10 p. |
artikel |